Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ICU
DateTimeSourceHeadlineSymbolCompany
05/14/20243:05PMGlobeNewswire Inc.SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
04/30/20247:30AMGlobeNewswire Inc.SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
04/17/20243:00PMGlobeNewswire Inc.SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
04/11/20247:30AMGlobeNewswire Inc.SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
03/27/20247:30AMGlobeNewswire Inc.SeaStar Medical to Restate Financials, Sets Business Update Call for April 17NASDAQ:ICUSeaStar Medical Holding Corporation
03/12/20247:30AMGlobeNewswire Inc.SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
03/11/20243:05PMGlobeNewswire Inc.SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024NASDAQ:ICUSeaStar Medical Holding Corporation
02/27/20247:30AMGlobeNewswire Inc.Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
02/22/20246:58AMGlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:ICUSeaStar Medical Holding Corporation
02/22/20246:53AMGlobeNewswire Inc.FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
02/01/20247:30AMGlobeNewswire Inc.SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyNASDAQ:ICUSeaStar Medical Holding Corporation
01/26/20247:05AMGlobeNewswire Inc.SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:ICUSeaStar Medical Holding Corporation
01/11/20243:05PMGlobeNewswire Inc.SeaStar Medical Appoints David A. Green as Chief Financial OfficerNASDAQ:ICUSeaStar Medical Holding Corporation
01/09/20247:30AMGlobeNewswire Inc.SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical IndicationsNASDAQ:ICUSeaStar Medical Holding Corporation
12/28/20237:30AMGlobeNewswire Inc.SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
12/13/20237:30AMGlobeNewswire Inc.SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNASDAQ:ICUSeaStar Medical Holding Corporation
11/14/20233:04PMGlobeNewswire Inc.SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
10/31/20237:00AMGlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
10/30/20237:00AMGlobeNewswire Inc.FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
10/18/20237:30AMGlobeNewswire Inc.FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
10/05/20237:30AMGlobeNewswire Inc.SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023NASDAQ:ICUSeaStar Medical Holding Corporation
10/03/20233:05PMGlobeNewswire Inc.SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:ICUSeaStar Medical Holding Corporation
09/29/20237:30AMGlobeNewswire Inc.FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
09/21/20238:35AMGlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
08/30/20233:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
08/29/20237:00AMGlobeNewswire Inc.Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood PurificationNASDAQ:ICUSeaStar Medical Holding Corporation
08/24/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
08/22/20237:00AMGlobeNewswire Inc.SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern TimeNASDAQ:ICUSeaStar Medical Holding Corporation
08/17/20234:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
08/17/20234:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:ICU